跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13 条关于
“Frizzled”
全部
13
临床试验
3
药物
2
机构
0
资讯
8
去年
Novel Frizzled 7 Antibody Shows Promise Against Wilms Tumor Through Wnt Pathway Disruption
去年
Surrozen Secures Key Patent for Antibody-Based Wnt Pathway Modulators with Potential in Retinal Disease Treatment
去年
āshibio Licenses Vantictumab for Rare Bone Disease ADO2 in Strategic Pipeline Expansion
去年
Surrozen Reports Strong Q2 2025 Turnaround with $39.7M Net Income, Advances Retinal Disease Pipeline
7个月前
MUSC Researchers Develop Novel Antibody Targeting SFRP2 to Combat Triple-Negative Breast Cancer Resistance
上个月
Surrozen Submits IND for SZN-8141, a Bifunctional Wnt Agonist/VEGF Antagonist for Diabetic Macular Edema
9个月前
Innova Therapeutics Acquires Enci Therapeutics to Advance First-in-Class SFRP2-Targeting Cancer Antibody
5个月前
Surrozen Advances Wnt-Based Retinal Therapeutics Pipeline, Plans IND Filing for SZN-8141 in Second Half of 2026